The effect of transoral robotic surgery on short-term outcomes and cost of care after oropharyngeal cancer surgery

Laryngoscope

Volumn 124, Issue 1, 2014, Pages 165-171

  Richmon, Jeremy D ^a   Quon, Harry ^a   Gourin, Christine G ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

complications; head and neck neoplasms; Nationwide Inpatient Sample; surgery; TORS; Transoral robotic surgery

Indexed keywords

ACUTE KIDNEY FAILURE; ACUTE LIVER FAILURE; ADULT; AGED; ARTICLE; CANCER MORTALITY; CROSS-SECTIONAL STUDY; EAR NOSE THROAT SURGERY; FEMALE; GLOSSECTOMY; HEALTH CARE COST; HEART DISEASE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LARYNGECTOMY; LENGTH OF STAY; LUNG EDEMA; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MANDIBLE RESECTION; MAXILLA RESECTION; MEDICAID; MIDDLE AGED; NECK DISSECTION; ORAL SURGERY; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROBOTICS; SEPSIS; STOMACH TUBE; TEACHING HOSPITAL; TONSILLECTOMY; TRACHEOSTOMY TUBE; TRANSORAL ROBOTIC SURGERY; URINARY TRACT INFECTION; COMPLICATIONS; ECONOMICS; HEAD AND NECK TUMOR; METHODOLOGY; NATIONWIDE INPATIENT SAMPLE; OROPHARYNX TUMOR; SURGERY; TIME; TORS; TREATMENT OUTCOME; VERY ELDERLY; OROPHARYNGEAL NEOPLASMS; PROCEDURES;

COMPLICATIONS; HEAD AND NECK NEOPLASMS; NATIONWIDE INPATIENT SAMPLE; SURGERY; TORS; TRANSORAL ROBOTIC SURGERY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; ROBOTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84895838130     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24358     Document Type: Article

References (34)

1. McLeod IK, Melder PC,. Da Vinci robot-assisted excision of a vallecular cyst: a case report. Ear Nose Throat J 2005; 84: 170-172.
2. Zhen W, Karnell LH, Hoffman HT, Funk GF, Buatti JM, Menck HR,. The National Cancer Data Base report on squamous cell carcinoma of the base of tongue. Head Neck 2004; 26: 660-674.
3. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-4301.
4. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
5. Quon H, Richmon JD,. Treatment deintensification strategies for HPV-associated head and neck carcinomas. Otolaryngol Clin North Am 2012; 45: 845-861.
6. Moore EJ, Olsen SM, Laborde RR, et al. Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc 2012; 87: 219-225.
7. Weinstein GS, Quon H, O'Malley BW Jr, Kim GG, Cohen MA,. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope 2010; 120: 1749-1755.
8. Weinstein GS, Quon H, Newman HJ, et al. Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. Arch Otolaryngol Head Neck Surg 2012; 138: 628-634.
9. Overview of the Nationwide Inpatient Sample. http://www.hcup-us.ahrq.gov/ nisoverview.jsp Accessed October 1, 2012.
10. Liu JH, Zingmond DS, McGory ML, et al. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 2006; 296: 1973-1980.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-383.
12. Romano P, Roos LL, Jollis JG,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993; 46: 1075-1079.
13. Neighbors CJ, Rogers M, Shenassa ED, et al. Ethnic/racial disparities in hospital procedure volume for lung resection for lung cancer. Med Care 1997; 45: 655-663.
14. Cost-to-Charge Ratio Files. http://www.hcup-us.ahrq.gov/db/state/ costtocharge.jsp. Accessed August 20, 2012.
15. Newhouse RP, Mills ME, Johantgen M, Provonost PJ,. Is there a relationship between service integration and differentiation and patient outcomes? Int J Integrated Care 2003; 3: 1-13.
16. U.S. Department of Labor; Bureau of Labor Statistics, Consumer Price Index Inflation Calculator. http://www.bls.gov/bls/inflation.htm. Accessed August 20, 2012.
17. Weinstein GS, O'Malley BW Jr, Snyder W, et al. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 2007; 133: 1220-1226.
18. Genden EM, Desai S, Sung CK,. Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck 2009; 31: 283-289.
19. Moore EJ, Olsen KD, Kasperbauer JL,. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope 2009; 119: 2156-2164.
20. Richmon JD, Agrawal N, Pattani KM,. Implementation of a TORS program in an academic medical center. Laryngoscope 2011; 121: 2344-2348.
21. Hurtuk A, Agrawal A, Old M, Teknos TN, Ozer E,. Outcomes of transoral robotic surgery: a preliminary clinical experience. Otolaryngol Head Neck Surg 2011; 145: 248-253.
22. Moore EJ, Hinni ML, Olsen KD, Price DL, Laborde RR, Inman JC,. Cost considerations in the treatment of oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2012; 146: 946-951.
23. Lin BM, Starmer HM, Gourin CG,. The relationship between depressive symptoms, quality of life, and swallowing function in head and neck cancer patients 1 year after definitive therapy. Laryngoscope 2012; 122: 1518-1525.
24. Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005; 61: 772-778.
25. Schwartz DL, Hutcheson K, Barringer D, et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010; 78: 1356-1365.
26. Sanguineti G, Gunn GB, Parker BC, Endres EJ, Zeng J, Fiorino C,. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011; 79: 52-59.
27. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68: 1289-1298.
28. Gourin CG, Johnson JT,. Surgical treatment of squamous cell carcinoma of the base of tongue. Head Neck 2001; 23: 653-660.
29. Leonhardt FD, Quon H, Abrahao M, O'Malley BW Jr, Weinstein GS,. Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function. Head Neck 2012; 34: 146-154.
30. Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS,. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2011; 137: 1112-1116.
31. Moore EJ, Olsen SM, Laborde RR, et al. Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc 2012; 87: 219-225.
32. More YI, Tsue TT, Girod DA, et al. Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers. JAMA Otolaryngol Head Neck Surg 2013; 139: 43-48.
33. Dowthwaite SA, Franklin JH, Palma DA, Fung K, Yoo J, Nichols AC,. The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature. ISRN Oncol 2012; 2012: 945162.
34. Li RJ, Richmon JD,. Transoral endoscopic surgery: new surgical techniques for oropharyngeal cancer. Otolaryngol Clin North Am 2012; 45: 823-844.